Table 1.
Patients Clinical Characteristics
| Characteristics | NSCLC (n=86) | LBL (n=44) | HC (n=40) | P-value |
|---|---|---|---|---|
| Age, years | 57.6 ± 9.1 | 58.2 ± 11.8 | 57.1 ± 8.6 | 0.387 |
| Sex | 0.964 | |||
| Male | 62 (72.1%) | 31 (70.5%) | 28 (70.0%) | |
| Female | 24 (27.9%) | 13 (29.5%) | 12 (30.0%) | |
| Smoking status | 0.125 | |||
| Non-smoker | 31 (36.0%) | 20 (45.5%) | 22 (55.0%) | |
| Former smoker | 55 (64.0%) | 24 (54.5%) | 18 (45.0%) | |
| Histology | ||||
| Adenocarcinoma | 46 (53.5%) | |||
| Squamous cell carcinoma | 26 (30.2%) | |||
| Large cell carcinoma | 14 (16.3%) | |||
| TNM stage | ||||
| I | 48 (55.8%) | |||
| II | 38 (44.2%) | |||
| Tumor size, cm | ||||
| < 3 | 41 (47.7%) | |||
| ≥ 3 | 45 (52.3%) | |||
| Lymph node metastasis | ||||
| Yes | 35 (40.7%) | |||
| No | 51 (59.3%) | |||
| LBL, % | ||||
| Tuberculosis | 15 (34.1%) | |||
| Hamartoma | 13 (29.5%) | |||
| Fungal infection | 9 (20.5%) | |||
| Inflammation | 5 (11.4%) | |||
| Granuloma | 2 (4.5%) |
Abbreviations: NSCLC, non-small cell lung cancer; LBL, lung benign lesion; HC, healthy control.